| Literature DB >> 27108886 |
Elisa Giorgio1, Andrea Ciolfi2,3, Elisa Biamino4, Viviana Caputo5, Eleonora Di Gregorio6, Elga Fabia Belligni4, Alessandro Calcia1, Elena Gaidolfi7, Alessandro Bruselles8, Cecilia Mancini1, Simona Cavalieri6, Cristina Molinatto4, Margherita Cirillo Silengo4, Giovanni Battista Ferrero4, Marco Tartaglia2, Alfredo Brusco1,6.
Abstract
Whole exome sequencing (WES) is a powerful tool to identify clinically undefined forms of intellectual disability/developmental delay (ID/DD), especially in consanguineous families. Here we report the genetic definition of two sporadic cases, with syndromic ID/DD for whom array-Comparative Genomic Hybridization (aCGH) identified a de novo copy number variant (CNV) of uncertain significance. The phenotypes included microcephaly with brachycephaly and a distinctive facies in one proband, and hypotonia in the legs and mild ataxia in the other. WES allowed identification of a functionally relevant homozygous variant affecting a known disease gene for rare syndromic ID/DD in each proband, that is, c.1423C>T (p.Arg377*) in the Trafficking Protein Particle Complex 9 (TRAPPC9), and c.154T>C (p.Cys52Arg) in the Very Low Density Lipoprotein Receptor (VLDLR). Four mutations affecting TRAPPC9 have been previously reported, and the present finding further depicts this syndromic form of ID, which includes microcephaly with brachycephaly, corpus callosum hypoplasia, facial dysmorphism, and overweight. VLDLR-associated cerebellar hypoplasia (VLDLR-CH) is characterized by non-progressive congenital ataxia and moderate-to-profound intellectual disability. The c.154T>C (p.Cys52Arg) mutation was associated with a very mild form of ataxia, mild intellectual disability, and cerebellar hypoplasia without cortical gyri simplification. In conclusion, we report two novel cases with rare causes of autosomal recessive ID, which document how interpreting de novo array-CGH variants represents a challenge in consanguineous families; as such, clinical WES should be considered in diagnostic testing.Entities:
Keywords: TRAPPC9; VLDRL; de novo CNV; intellectual disability; whole exome sequencing
Mesh:
Substances:
Year: 2016 PMID: 27108886 DOI: 10.1002/ajmg.a.37649
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802